Evidence map›Paper›PMID 26983701›Full record

ReviewVirchows Archiv : an international journal of pathology2016

The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.

Emeline Durieux, Françoise Descotes, Claire Mauduit, Myriam Decaussin, Serge Guyetant, Mojgan Devouassoux-Shisheboran

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Virchows Archiv : an international journal of pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Expanding the Molecular Data ofHuman mutation · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Molecular Landscape of Pediatric Thyroid Cancer: A Review.Diagnostics (Basel, Switzerland) · 2022
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Three synchronous malignancies in a patient with DICER1 syndrome.European journal of cancer (Oxford, England : 1990) · 2018
    Article
  14. DistinctJCO precision oncology · 2018
    Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Emeline DurieuxDepartment of Pathology, Hospices Civils de Lyon, Hôpital de la Croix Rousse, Université Lyon I, 103 Grande rue de la Croix Rousse, 69004, Lyon, France.
Françoise DescotesBiochimie Biologie Moléculaire, Hospices Civils de Lyon, Centre hospitalier Lyon Sud, 69495 Pierre Bénite, Lyon, France.
Claire MauduitDepartment of Pathology, Hospices Civils de Lyon, Centre hospitalier Lyon Sud, Université Lyon I, 69495 Pierre Bénite, Lyon, France.
Myriam DecaussinDepartment of Pathology, Hospices Civils de Lyon, Centre hospitalier Lyon Sud, Université Lyon I, 69495 Pierre Bénite, Lyon, France.
Serge GuyetantDepartment of Pathology, CHRU Tours, 37044 Cedex 9, Tours, France.
Mojgan Devouassoux-ShisheboranDepartment of Pathology, Hospices Civils de Lyon, Hôpital de la Croix Rousse, Université Lyon I, 103 Grande rue de la Croix Rousse, 69004, Lyon, France. mojgan.devouassoux@chu-lyon.fr.
Université Claude Bernard Lyon 1 · FRCentre Hospitalier Universitaire de Tours · FRHôpital Lyon Sud · FRHospices Civils de Lyon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The DICER1 gene encodes an endoribonuclease involved in the production of mature microRNAs which regulates gene expression through several mechanisms. Carriers of germline DICER1 mutations are predisposed to a rare cancer syndrome, the DICER1 syndrome. Pleuropulmonary blastoma is the most frequent lesion seen in this syndrome. Thyroid abnormalities are also a common finding, essentially concerning multinodular goiter. However, differentiated thyroid carcinoma is infrequently seen in such pedigrees. In addition to germline DICER1 mutations, specific somatic mutations have been identified in the DICER1 RNase IIIb catalytic domain in several tumor types, including ovarian Sertoli-Leydig cell tumors. We report two cases of differentiated thyroid carcinoma associated with ovarian Sertoli-Leydig cell tumor and with a heterozygous DICER1 gene mutation, occurring in two unrelated young girls without pleuropulmonary blastoma. Both thyroid carcinomas showed an E1813 mutation in exon 25 while the ovarian tumors harboured a somatic mutation in E1705 in exon 24 and a D1709 mutation in exon 25. Our observations confirm that the occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome. We contend that the possibility of a relationship between sporadic thyroid carcinoma in young patients and somatic DICER1 gene mutation needs further investigation.

Indexed as

AdolescentChildDEAD-box RNA HelicasesFemaleHumansMutationOvarian NeoplasmsPedigreePulmonary BlastomaRibonuclease IIISertoli-Leydig Cell TumorThyroid NeoplasmsDEAD-box RNA HelicasesDICER1 protein, humanRibonuclease IIIDICER-1familial neoplasiaPleuropulmonary blastomaSertoli-Leydig cell tumorThyroid carcinoma

Identifiers

PMID26983701
OpenAlexW2297417946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.